Silk Road Medical, Inc (SILK) — Financial statements
Income statement, balance sheet, and cash flow for Silk Road Medical, Inc — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 177↑27.8% | 139↑36.6% | 101↑34.9% | 75↑18.7% | 63 | |
| Cost of Revenue | 50↑32.1% | 38↑48.8% | 25↑19.5% | 21↑33.7% | 16 | |
| Gross Profit | 127↑26.1% | 101↑32.5% | 76↑41.0% | 54↑13.7% | 47 | |
| Operating Expenses | ||||||
| R&D Expenses | 41↑13.4% | 36↑34.4% | 27↑27.5% | 21↑73.3% | 12 | |
| General & Administrative Expenses | 145↑24.7% | 116↑20.6% | 96↑27.7% | 75↑19.8% | 63 | |
| Selling & Marketing Expenses | 0.46↑32.9% | 0.35↑57.0% | 0.22↑13.9% | 0.19↓46.4% | 0.36 | |
| SG&A Expenses | 145↑24.7% | 116↑20.7% | 96↑27.6% | 76↑19.5% | 63 | |
| Other Expenses | 0.44↑332.6% | -0.19↓726.1% | -0.02↑71.3% | -0.08 | 0.00 | |
| Operating Expenses | 186↑22.0% | 153↑23.7% | 123↑27.6% | 97↑28.2% | 75 | |
| Total Costs & Expenses | 236↑24.0% | 191↑28.0% | 149↑26.1% | 118↑29.2% | 91 | |
| Operating Results | ||||||
| Operating Income | -59↓14.0% | -52↓9.6% | -47↓10.8% | -43↓52.7% | -28 | |
| Depreciation & Amortization | 4↑19.7% | 3↑65.1% | 2↑38.0% | 1↑7.5% | 1 | |
| EBITDA | -45↑3.6% | -47↓2.6% | -46↓9.8% | -41↑10.2% | -46 | |
| EBIT | -49↑2.1% | -50↓5.5% | -47↓10.1% | -43↑9.5% | -47 | |
| Interest & Other Income | ||||||
| Net Interest Income | 3↑220.0% | -3↓10.8% | -2↑29.8% | -3↓0.3% | -3 | |
| Interest Income | 10↑294.0% | 3↑1176.3% | 0.20↓82.1% | 1↓33.3% | 2 | |
| Interest Expense | 7↑34.8% | 5↑102.5% | 3↓42.9% | 4↓10.9% | 5 | |
| Non-Operating Income | -10↓397.1% | -2↓1095.4% | -0.18↓284.2% | 0.10↓99.5% | 19 | |
| Other Income / Expenses | 4↑217.4% | -3↓28.3% | -2↑48.0% | -5↑81.5% | -24 | |
| Income Before Tax | -56↓1.3% | -55↓10.4% | -50↓5.2% | -47↑9.6% | -52 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -56↓1.3% | -55↓10.4% | -50↓5.2% | -47↑9.6% | -52 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -56↑3.9% | -58↓15.1% | -50↓0.0% | -50↑10.1% | -56 | |
| Bottom-Line Net Income | -56↓1.3% | -55↓10.4% | -50↓5.2% | -47↑9.6% | -52 | |
| EPS (Basic) | -1.44↑11.1% | -1.62↓11.7% | -1.45↑5.2% | -1.53↑37.3% | -2.44 | |
| EPS (Diluted) | -1.44↑11.1% | -1.62↓11.7% | -1.45↑5.2% | -1.53↑37.3% | -2.44 | |
| Weighted Average Shares | 39↑8.5% | 36↑3.3% | 35↑5.1% | 33↑43.6% | 23 | |
| Weighted Average Diluted Shares | 39↑8.5% | 36↑3.3% | 35↑5.1% | 33↑43.6% | 23 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.